182 related articles for article (PubMed ID: 18991351)
1. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.
Zhang N; Yu JT; Yang Y; Yang J; Zhang W; Tan L
Brain Res; 2011 May; 1391():147-53. PubMed ID: 21443865
[TBL] [Abstract][Full Text] [Related]
3. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
4. GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.
Dobson-Stone C; Polly P; Korgaonkar MS; Williams LM; Gordon E; Schofield PR; Mather K; Armstrong NJ; Wen W; Sachdev PS; Kwok JB
PLoS One; 2013; 8(8):e71750. PubMed ID: 23951236
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
6. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
[TBL] [Abstract][Full Text] [Related]
7. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
[TBL] [Abstract][Full Text] [Related]
8. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
9. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
[TBL] [Abstract][Full Text] [Related]
10. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
[TBL] [Abstract][Full Text] [Related]
11. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
12. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
13. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
Strickland SL; Reddy JS; Allen M; N'songo A; Burgess JD; Corda MM; Ballard T; Wang X; Carrasquillo MM; Biernacka JM; Jenkins GD; Mukherjee S; Boehme K; Crane P; Kauwe JS; Ertekin-Taner N;
Alzheimers Dement; 2020 Jul; 16(7):983-1002. PubMed ID: 32400971
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.
Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA
Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211
[TBL] [Abstract][Full Text] [Related]
15. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk.
Mateo I; Vázquez-Higuera JL; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2009 Aug; 120(2):130-3. PubMed ID: 19154537
[TBL] [Abstract][Full Text] [Related]
16. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
[TBL] [Abstract][Full Text] [Related]
17. The association between single nucleotide polymorphisms of GSK 3β gene and sporadic Alzheimer's disease in a cohort of southern Chinese Han population.
Li J; Zeng F; Deng J; Zhu J; Li L; Zhang T; Liu J; Zhang LL; Gao CY; Zhang M; Xu ZQ; Zhou HD; Wang YJ
Neurotox Res; 2014 Nov; 26(4):447-53. PubMed ID: 25141968
[TBL] [Abstract][Full Text] [Related]
18. The MAPT H1 haplotype is associated with tangle-predominant dementia.
Santa-Maria I; Haggiagi A; Liu X; Wasserscheid J; Nelson PT; Dewar K; Clark LN; Crary JF
Acta Neuropathol; 2012 Nov; 124(5):693-704. PubMed ID: 22802095
[TBL] [Abstract][Full Text] [Related]
19. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases.
García-Gorostiaga I; Sánchez-Juan P; Mateo I; Rodríguez-Rodríguez E; Sánchez-Quintana C; del Olmo SC; Vázquez-Higuera JL; Berciano J; Combarros O; Infante J
Ann Neurol; 2009 Jun; 65(6):759-61; author reply 761-2. PubMed ID: 19557862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
